Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT05188612
Recruiting Observational

International Survey of Acute Coronavirus Syndromes-COVID-19

NCT05188612 · tracked via the Priya Life Science Spain tracker
Sponsor
University of Bologna
Phase
Observational
Started
2021-12-01
Last updated
2026-05-01

Condition(s) studied

COVID-19

Investigational drug(s) / intervention(s)

Observational (registry)

Observational (registry): Observational (Patient Registry)

Study summary

In response to the COVID-19 crisis, ISACS-TC has promoted a new registry of the existing and further centers of the same geographic areas to support clinical research to prevent, and treat the COVID-19 illness. These efforts are made possible by the generous contributions of clinical research volunteers in some of the countries participating to the prior acute coronary syndrome network.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years (male or female) * Patients admitted to any hospital center with a confirmed diagnosis of COVID-19 infection. Exclusion Criteria: • Underage or not able to give informed consent

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
University of Bologna Bologna Bologna Recruiting
IR-Hospital de la Santa Creu i Sant Pau, UAB Barcelona Spain Recruiting

More University of Bologna trials in Spain

Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study Active, not recruiting

Other trials for the same condition

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 Active, not recruiting
Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years Starting soon
Prevalence of Long COVID-19 in the Canary Islands Recruiting
Profile of COVID-19 Patients Related to Fatigue Active, not recruiting
Antihistamines, Amantadine and Evolution of COVID-19 Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05188612 on ClinicalTrials.gov ↗ ← All trials in Spain